U.S. Patent Innovations LLC awards Dr. Keidar $5.3M in funding for novel plasma cancer therapy

September 05, 2017

Photo of Dr. Michael Keidar

Dr. Michael Keidar has received $5.3 million in funding from U.S. Patent Innovations LLC for a five-year project titled “Plasma Medicine Initiative” (PMI).  PMI aims to revolutionize cancer therapy by introducing a novel modality in cancer treatment that uses a cool-to-the-touch jet of ionized gases, or cold atmospheric plasma (“CAP”).  Read the GW Today article on this promising technology and the partnership.